Antidepressant medicine sales in Germany are forecasted to remain constant from 2024 to 2028, with a projected per capita value of 11.7 USD PPP annually. Due to the lack of available data for 2023, a direct year-on-year percentage variation cannot be precisely calculated, but the stability in forecasts suggests no anticipated growth or decline over this period.
The absence of change over these years indicates a relatively static market for antidepressants. Notable trends to monitor include potential impacts of regulatory changes, public health initiatives aimed at mental health awareness, and advances in alternative therapies which could influence the market dynamics.
